Literature DB >> 10563279

The feasibility of using automated data to assess guideline-concordant care for schizophrenia.

T J Hudson1, R R Owen, A E Lancaster, L Mason.   

Abstract

This study examines the feasibility of using automated computer data versus written medical record data to identify patients receiving guideline concordant treatment for schizophrenia. Central elements of care derived from published practice guidelines for schizophrenia were examined for a convenience sample of 28 patients who received acute inpatient treatment. The results showed that automated data were superior to medical record data for identifying some elements of guideline-concordant treatment. Not only were the elements of care examined in this study clinically significant and within the current capabilities of the existing computer information system, but they are also likely related to patient outcomes. Implications for clinical care, future research, and health care quality improvement efforts are discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10563279     DOI: 10.1023/a:1020526327467

Source DB:  PubMed          Journal:  J Med Syst        ISSN: 0148-5598            Impact factor:   4.460


  24 in total

1.  Computerized decision support based on a clinical practice guideline improves compliance with care standards.

Authors:  D F Lobach; W E Hammond
Journal:  Am J Med       Date:  1997-01       Impact factor: 4.965

Review 2.  Guidelines for the dosage of antipsychotic drugs.

Authors:  H Beckmann; G Laux
Journal:  Acta Psychiatr Scand Suppl       Date:  1990

3.  Performance measurement: problems and solutions.

Authors:  D M Eddy
Journal:  Health Aff (Millwood)       Date:  1998 Jul-Aug       Impact factor: 6.301

4.  A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity.

Authors:  G P Samsa; J T Hanlon; K E Schmader; M Weinberger; E C Clipp; K M Uttech; I K Lewis; P B Landsman; H J Cohen
Journal:  J Clin Epidemiol       Date:  1994-08       Impact factor: 6.437

5.  The measurement of quality of care in the Veterans Health Administration.

Authors:  J Halpern
Journal:  Med Care       Date:  1996-03       Impact factor: 2.983

6.  Is real-time quality assessment of health care an achievable goal?

Authors:  D A Terreros; V J Robinson; W L Hodson
Journal:  Ann Clin Lab Sci       Date:  1994 Jan-Feb       Impact factor: 1.256

7.  Antipsychotic drug exposure in a health maintenance organization.

Authors:  R E Johnson; B H McFarland
Journal:  Med Care       Date:  1993-05       Impact factor: 2.983

8.  Measuring quality of care with explicit process criteria before and after implementation of the DRG-based prospective payment system.

Authors:  K L Kahn; W H Rogers; L V Rubenstein; M J Sherwood; E J Reinisch; E B Keeler; D Draper; J Kosecoff; R H Brook
Journal:  JAMA       Date:  1990-10-17       Impact factor: 56.272

9.  Alternative to mental hospital treatment. I. Conceptual model, treatment program, and clinical evaluation.

Authors:  L I Stein; M A Test
Journal:  Arch Gen Psychiatry       Date:  1980-04

10.  Measuring the quality of outpatient treatment for schizophrenia.

Authors:  A S Young; G Sullivan; M A Burnam; R H Brook
Journal:  Arch Gen Psychiatry       Date:  1998-07
View more
  3 in total

1.  Regional variation in medical classification agreement: benchmarking the coding gap.

Authors:  Daniel Lorence
Journal:  J Med Syst       Date:  2003-10       Impact factor: 4.460

2.  Use of electronic medical record data for quality improvement in schizophrenia treatment.

Authors:  Richard R Owen; Carol R Thrush; Dale Cannon; Kevin L Sloan; Geoff Curran; Teresa Hudson; Mark Austen; Mona Ritchie
Journal:  J Am Med Inform Assoc       Date:  2004-06-07       Impact factor: 4.497

3.  Prediction of the period of psychotic episode in individual schizophrenics by simulation-data construction approach.

Authors:  Chun-Jung Huang; Hsiao-Fan Wang; Hsien-Jane Chiu; Tsuo-Hung Lan; Tsung-Ming Hu; El-Wui Loh
Journal:  J Med Syst       Date:  2009-05-29       Impact factor: 4.460

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.